MetLife Investment Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,302
| Closed | -$834K | – | 2373 |
|
|
2019
Q3 | $834K | Hold |
12,302
| – | – | 0.01% | 1160 |
|
|
2019
Q2 | $716K | Buy |
12,302
+3,468
| +39% | +$202K | 0.01% | 1279 |
|
|
2019
Q1 | $619K | Hold |
8,834
| – | – | 0.01% | 1332 |
|
|
2018
Q4 | $569K | Hold |
8,834
| – | – | 0.01% | 1285 |
|
|
2018
Q3 | $620K | Sell |
8,834
-2,155
| -20% | -$151K | 0.01% | 1395 |
|
|
2018
Q2 | $554K | Buy |
10,989
+2,179
| +25% | +$110K | 0.01% | 1354 |
|
|
2018
Q1 | $276K | Hold |
8,810
| – | – | ﹤0.01% | 1726 |
|
|
2017
Q4 | $301K | Buy |
+8,810
| New | +$301K | ﹤0.01% | 1710 |
|